Showing 1321-1330 of 1648 results for "".
- ASDS News: Patients Love Galderma's Investigational Liquid Botulinum Toxinhttps://modernaesthetics.com/news/asds-news-patients-love-galdermas-investigational-liquid-botulinum-toxin/2473312/Galderma's investigational ready-to-use liquid botulinum toxin RelabotulinumtoxinA scored high patient satisfaction and psychological well-being ratings for the treatment of glabellar lines and lateral canthal lines in addition to previously reported safety and efficacy, according to pre
- Right to Repair: How Developments Could Affect Aesthetics Practiceshttps://modernaesthetics.com/news/right-to-repair-how-developments-could-affect-aesthetics-practices/2473311/Recent action on the federal level has renewed interest in “Right to Repair” legislation, and the medical aesthetics industry is eyeing developments that might directly impact aesthetic practices and medspas. Right to Repair legislation dates back to the 1970s, and mos
- BeautyHealth’s Hydrafacial Teams Up with JLohttps://modernaesthetics.com/news/beautyhealths-hydrafacial-teams-up-with-jlo/2473309/The BeautyHealth Company is rolling out the Hydrafacial x JLo Beauty Booster. “I'm so excited to partner with Hydrafacial to create the new JLo Beauty Booster,” says founder of JLo Beauty Jennifer Lopez in a news release. “Hydrafacial is one of my favorite treatmen
- Power Move: UFC Performance Institute to Use Lutronic Accufit for Training, Rehabhttps://modernaesthetics.com/news/power-move-ufc-performance-institute-to-use-lutronic-accufit-for-training-rehab/2473308/Lutronic's Accufit will now be made available for use to UFC fighters and other elite athletes through the UFC Performance Institute. "Accufit provides a higher energy multi-dimensional muscle workout, and the body contouring iprovement is dramatic. This 3rd generation intellig
- L'Oréal USA to Open New Research & Innovation Center in New Jerseyhttps://modernaesthetics.com/news/loreal-usa-to-open-new-research-innovation-center-in-new-jersey/2473305/L'Oréal USA is opening a new, state-of-the-art Research & Innovation (R&I) Center in Clark, New Jersey, replacing its existing facilities that it has occupied in the area for more than six decades. The $140 million development project represents the most significant investment
- BuildMyHealth Names First Chief Revenue Officerhttps://modernaesthetics.com/news/buildmyhealth-points-first-chief-revenue-officer/2473302/BuildMyHealth, developer of the No Surprises Act price transparency and lead conversion platform, has its first Chief Revenue Officer. Chad Sawyer was previously a national sales executive with both Crystal Clear Digital Marketing and Patient Now. In those roles, Mr. Sawyer helped hundreds of pra
- Allergan Aesthetics and BOTOX Cosmetic Reveal New 'See Yourself' Campaign Casthttps://modernaesthetics.com/news/allergan-aesthetics-and-botox-cosmetic-reveal-new-see-yourself-campaign-cast/2473299/Allergan Aesthetics is unveiling the 25 real patients – of all forms, genders, ethnicities and backgrounds – who were selected to participate in the latest iteration of the BOTOX Cosmetic 'See Yourself' campaign. After receiving nearly 20,000 submissions t
- FDA Issues Safety Alert for SCC and Various Lymphomas in Scar Tissue around Breast Implantshttps://modernaesthetics.com/news/fda-issues-safety-alert-for-scc-and-various-lymphomas-in-scar-tissue-around-breast-implants/2473297/The U.S. Food and Drug Administration (FDA) is informing patients and providers about reports of squamous cell carcinoma (SCC) and various lymphomas located in the capsule or scar tissue around breast implants. “After an initial extensive review, we currently believe that th
- CARE Curriculum Launched by DREAM Initiative from Allergan Aesthetics, SkinBetter Sciencehttps://modernaesthetics.com/news/care-curriculum-launched-by-dream-initiative-from-allergan-aesthetics-skinbetter-science/2473296/The DREAM Initiative®, developed by Allergan Aesthetics and skinbetter science®, has supported the development of a racial equity curriculum for dermatology residency programs. The Curriculum f
- FDA Approves Daxxify from Revancehttps://modernaesthetics.com/news/fda-approves-daxxify-from-revance/2473295/Daxxify™ (DaxibotulinumtoxinA-lanm) from Revance is FDA approved for the temporary improvement of moderate to severe frown lines (glabellar lines) in adults. Daxxify is the first and only neuromodulator stabilized with Peptide Exchange Technology™ (PXT) and is free of both human serum